Skip to main content
Premium Trial:

Request an Annual Quote

Proxeon, Molecular Connections, Accelrys, Protein Lounge, Marijn Dekkers, James Glover, James Glynn

Premium

New Products

Proxeon launched last week a "protein-centric" data warehouse called ProteinCenter that integrates the contents of a number of public protein sequence databases and bioinformatics tools with scientists' own experimental systems biology data.


Molecular Connections has released a new version of its NetPro curated database of protein and small-molecule interactions. The current version offers kinetic information, which includes data on time, concentration, association/dissociation constants, and inhibitory constants, and is available for free for all existing and new NetPro customers. The new version also includes Mutation and Knockout database modules, which are optional.


Accelrys has released the Catalyst Jubilant Small Molecules Databases Suite 2006, which provides a collection of known inhibitors of kinases, proteases, GPCR, nuclear receptors, and ion channels. The databases, curated by Jubilant Biosys, contain more than a million compounds and are available in Catalyst 3D format.


Protein Lounge has released Pathway Builder 2.0, a program for drawing signal transduction pathways. A demo is available at http://www.proteinlounge.com/pathwaybuilder.asp.

 

Movers & Shakers

Thermo Electron is paying chief executive Marijn Dekkers a bonus of more than $1.3 million, according to regulatory filings last week. Dekkers' 2006 salary is just over one million dollars, the filing said.


James Glover is retiring from Beckman Coulter, the company announced last week.

The company has started a search to replace Glover as senior vice president and chief financial officer.


James Glynn is retiring from Invitrogen's board on April 21, the company said last week.

Glynn has served the company for almost ten years and retires as chief executive emeritus.

Invitrogen said that there will be only nine directors after Glynn's departure.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.